A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential Hypertension
Clinical trial NCT06438172 · COMPLETED
Trial details
- NCT number
- NCT06438172
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-25
- Primary completion
- 2024-12-02
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.